Rein Therapeutics annual free cash flow
2015
2017
2018
2019
2020
2021
Rein Therapeutics Free Cash Flow (FCF) History (RNTX)
Rein Therapeutics reported −$23.9M in free cash flow for fiscal 2021, a decrease of $3.4M from the previous fiscal year.
View full Rein Therapeutics company overviewRein Therapeutics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2021 | 2021-12-31 | −$23.9M | −$3.4M | — | — |
| 2020 | 2020-12-31 | −$20.5M | $6.1M | — | — |
| 2019 | 2019-12-31 | −$26.6M | $5.7M | — | — |
| 2018 | 2018-12-31 | −$32.3M | −$11.7M | — | — |
| 2017 | 2017-12-31 | −$20.7M | −$8.9M | — | — |
| 2015 | 2015-12-31 | −$11.8M | — | — | — |
Rein Therapeutics quarterly free cash flow
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2021 | 2021-12-31 | −$6.3M | −$1.2M | — | — |
| Q3 2021 | 2021-09-30 | −$7.3M | −$945,000 | — | — |
| Q2 2021 | 2021-06-30 | −$3.8M | $3.2M | — | — |
| Q1 2021 | 2021-03-31 | −$6.6M | −$865,000 | — | — |
| Q3 2020 | 2020-09-30 | −$5.0M | $2.6M | — | — |
| Q4 2019 | 2019-12-31 | −$6.3M | $2.3M | — | — |
| Q3 2019 | 2019-09-30 | −$7.0M | $2.2M | — | — |
| Q2 2019 | 2019-06-30 | −$5.7M | $2.0M | — | — |
| Q1 2019 | 2019-03-31 | −$7.6M | −$692,000 | — | — |
| Q4 2018 | 2018-12-31 | −$8.6M | −$2.7M | — | — |
| Q3 2018 | 2018-09-30 | −$9.2M | −$3.9M | — | — |
| Q2 2018 | 2018-06-30 | −$7.7M | −$4.1M | — | — |
| Q1 2018 | 2018-03-31 | −$6.9M | −$946,000 | — | — |
| Q4 2017 | 2017-12-31 | −$5.9M | — | — | — |
| Q3 2017 | 2017-09-30 | −$5.3M | — | — | — |
| Q2 2017 | 2017-06-30 | −$3.5M | — | — | — |
| Q1 2017 | 2017-03-31 | −$6.0M | — | — | — |
Rein Therapeutics free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$11.8M to −$23.9M, a net decrease of $12.1M. Rein Therapeutics's latest reported quarter, Q4 2021, generated −$6.3M in free cash flow, a decrease of $1.2M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Rein Therapeutics filings at SEC.gov ↗